000 | 01012 a2200289 4500 | ||
---|---|---|---|
005 | 20250516025840.0 | ||
264 | 0 | _c20120106 | |
008 | 201201s 0 0 eng d | ||
022 | _a1522-9645 | ||
024 | 7 |
_a10.1093/eurheartj/ehr044 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGheorghiade, Mihai | |
245 | 0 | 0 |
_aBeyond dyspnoea as an endpoint in acute heart failure trials. _h[electronic resource] |
260 |
_bEuropean heart journal _cJun 2011 |
||
300 |
_a1442-5 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 |
_aAdenosine A1 Receptor Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aDyspnea _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aXanthines _xadministration & dosage |
700 | 1 | _aRuschitzka, Frank | |
773 | 0 |
_tEuropean heart journal _gvol. 32 _gno. 12 _gp. 1442-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/ehr044 _zAvailable from publisher's website |
999 |
_c20661330 _d20661330 |